Page last updated: 2024-08-21

levonorgestrel and ER-Negative PR-Negative HER2-Negative Breast Cancer

levonorgestrel has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Coricovac, D; Dehelean, CA; Dobrescu, A; Draghici, GA; Malita, D; Marcovici, I; Navolan, D; Olaru, F; Simu, S	1

Other Studies

1 other study(ies) available for levonorgestrel and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel. Molecules (Basel, Switzerland), 2021, May-08, Volume: 26, Issue:9 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Signal Transduction; Triple Negative Breast Neoplasms	2021

Article

Year

Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel.

Molecules (Basel, Switzerland), 2021, May-08, Volume: 26, Issue:9

Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Shape; Cell Survival; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Signal Transduction; Triple Negative Breast Neoplasms

2021